{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:25:44Z","timestamp":1791062744148,"version":"4.1.0"},"reference-count":321,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.phrs.2024.107101","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T04:20:45Z","timestamp":1707279645000},"page":"107101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["The VEGFs\/VEGFRs system in Alzheimer\u2019s and Parkinson\u2019s diseases: Pathophysiological roles and therapeutic implications"],"prefix":"10.1016","volume":"201","author":[{"given":"Claudia","family":"Ceci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Miguel","family":"Lacal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Barbaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Ledonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107101_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"Lohela","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","article-title":"Vascular endothelial growth factor: a neurovascular target in neurological diseases","volume":"12","author":"Lange","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phrs.2018.08.023","article-title":"Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors","volume":"136","author":"Lacal","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21041388","article-title":"Role of VEGFs\/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models","volume":"21","author":"Ceci","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dev.151019","article-title":"Vascular endothelial growth factor signaling in development and disease","volume":"145","author":"Karaman","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.phrs.2024.107101_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1312256","article-title":"The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor","volume":"255","author":"de Vries","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107101_bib8","doi-asserted-by":"crossref","first-page":"26690","DOI":"10.1016\/S0021-9258(19)61431-6","article-title":"The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1","volume":"275","author":"Fuh","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107101_bib9","doi-asserted-by":"crossref","first-page":"25520","DOI":"10.1074\/jbc.M102315200","article-title":"Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121)","volume":"276","author":"Whitaker","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107101_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4615-0119-0_7","article-title":"The interaction of neuropilin-1 and neuropilin-2 with tyrosine-kinase receptors for VEGF","volume":"515","author":"Neufeld","year":"2002","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200903137","article-title":"Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3","volume":"188","author":"Xu","year":"2010","journal-title":"J. Cell Biol.."},{"key":"10.1016\/j.phrs.2024.107101_bib12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2005-11-4447","article-title":"Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration","volume":"108","author":"Favier","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2024.107101_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and therapeutic potential of VEGF in the nervous system","volume":"89","author":"De Almodovar","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2024.107101_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1050-1738(01)00140-2","article-title":"The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis","volume":"12","author":"Neufeld","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1242\/jcs.114.5.853","article-title":"The splice variants of vascular endothelial growth factor (VEGF) and their receptors","volume":"114","author":"Robinson","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19041264","article-title":"Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2","volume":"19","author":"Peach","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib17","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1016\/S0021-9258(18)35712-0","article-title":"Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms","volume":"267","author":"Houck","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107101_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1091\/mbc.e09-07-0590","article-title":"Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action","volume":"21","author":"Ferrara","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.phrs.2024.107101_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1012214931986","article-title":"Ectodomain shedding of VEGF183, a novel isoform of vascular endothelial growth factor, promotes its mitogenic activity in vitro","volume":"4","author":"Jingjing","year":"2001","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phrs.2024.107101_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molmed.2011.11.006","article-title":"Complicated life, complicated VEGF-B","volume":"18","author":"Li","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2018.00039","article-title":"Vascular endothelial growth factor B and its signaling","volume":"5","author":"Lal","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib22","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1172\/JCI83967","article-title":"Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD","volume":"126","author":"Bui","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107101_bib23","first-page":"335","article-title":"The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: fundamentals and embryonic development","volume":"25","author":"Krebs","year":"2013","journal-title":"Vasomed"},{"key":"10.1016\/j.phrs.2024.107101_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2018.00007","article-title":"Biology of vascular endothelial growth factor C in the morphogenesis of lymphatic vessels","volume":"6","author":"Rauniyar","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.phrs.2024.107101_bib25","first-page":"1","article-title":"Vascular endothelial growth factor-D ( VEGF-D): an angiogenesis bypass in malignant tumors","volume":"24","author":"Mahak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"44","author":"De Falco","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib27","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.0914052107","article-title":"Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib29","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","article-title":"A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-\u03b3 and DNA synthesis in vascular endothelial cells","volume":"20","author":"Takahashi","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2024.107101_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1386-6346(03)00112-8","article-title":"ERK\/MAPK-dependent PI3K\/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells","volume":"26","author":"Takahashi","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib31","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1093\/emboj\/20.17.4762","article-title":"Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C\/D receptor VEGFR-3","volume":"20","author":"M\u00e4kinen","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2024.107101_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ncomms1977","article-title":"The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis","volume":"3","author":"Cudmore","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107101_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/ATVBAHA.114.303215","article-title":"Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction","volume":"35","author":"Domigan","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.2004235","article-title":"A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes","volume":"7","author":"Warren","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.phrs.2024.107101_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"2","author":"Koch","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19051306","article-title":"Positive and negative regulation of angiogenesis by soluble vascular endothelial growth factor receptor-1","volume":"19","author":"Failla","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phrs.2024.107101_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1152\/ajpcell.00389.2001","article-title":"Mechanisms of normal and tumor-derived angiogenesis","volume":"282","author":"Papetti","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.phrs.2024.107101_bib39","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107101_bib40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.biopha.2018.12.022","article-title":"Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases","volume":"110","author":"Fallah","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2024.107101_bib41","first-page":"1","article-title":"Molecular bases of VEGFR-2-mediated physiological function and pathological role","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5322-0","article-title":"VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer","volume":"19","author":"Lian","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phrs.2024.107101_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3578-9","article-title":"VEGFR2 regulates endothelial differentiation of colon cancer cells","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phrs.2024.107101_bib44","first-page":"50","article-title":"Tumor angiogenesis and VEGFR-2: mechanism, pathways and current biological therapeutic interventions","volume":"22","author":"Shah","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.phrs.2024.107101_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2024.107101_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbcan.2003.09.002","article-title":"Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?","volume":"1654","author":"Luttun","year":"2004","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phrs.2024.107101_bib47","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1078-0432.CCR-04-1564","article-title":"Anti-Flt1 peptide, a vascular endothelial growth factor receptor 1 - specific hexapeptide, inhibits tumor growth and metastasis","volume":"11","author":"Bae","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107101_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2021.100954","article-title":"VEGFR1 signaling in retinal angiogenesis and microinflammation","volume":"84","author":"Uemura","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.phrs.2024.107101_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00858-6","article-title":"Vasculogenic mimicry in carcinogenesis and clinical applications","volume":"13","author":"Luo","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2024.107101_bib50","doi-asserted-by":"crossref","first-page":"72868","DOI":"10.18632\/oncotarget.12108","article-title":"Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding","volume":"7","author":"Graziani","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2024.107101_bib51","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3892\/ijo.2016.3362","article-title":"Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness","volume":"48","author":"Pagani","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.phrs.2024.107101_bib52","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PLGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/cvr\/cvp380","article-title":"Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions","volume":"86","author":"Roncal","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib54","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1182\/blood-2006-04-016030","article-title":"Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes\/macrophages","volume":"108","author":"Murakami","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2024.107101_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.CIR.104.3.358","article-title":"Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect","volume":"104","author":"Aase","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2024.107101_bib56","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCRESAHA.108.178459","article-title":"Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy","volume":"103","author":"Karpanen","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib57","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/ATVBAHA.107.158725","article-title":"Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium","volume":"28","author":"Li","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib58","first-page":"913","article-title":"VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats","volume":"118","author":"Li","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107101_bib59","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/cam.3.4.9459","article-title":"VEGF-B: a survival, or an angiogenic factor?","volume":"3","author":"Li","year":"2009","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.phrs.2024.107101_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells11244134","article-title":"Therapeutic potential of VEGF-B in coronary heart disease and heart failure: dream or vision?","volume":"11","author":"Mallick","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107101_bib61","doi-asserted-by":"crossref","first-page":"13144","DOI":"10.1073\/pnas.1616168113","article-title":"VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection","volume":"113","author":"R\u00e4s\u00e4nen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/10715762.2018.1554901","article-title":"Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B\/AMPK\/eNOS\/NO signalling pathway","volume":"53","author":"Feng","year":"2019","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2016.09.016","article-title":"Resveratrol attenuates myocardial ischemia\/reperfusion injury through up-regulation of vascular endothelial growth factor B","volume":"101","author":"Yang","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2019.01.018","article-title":"Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B","volume":"79","author":"Tian","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2024.107101_bib65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phrs.2019.03.002","article-title":"Novel function of VEGF-B as an antioxidant and therapeutic implications","volume":"143","author":"Chen","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib66","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1073\/pnas.1801379115","article-title":"VEGF-B is a potent antioxidant","volume":"115","author":"Arjunan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib67","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/acschemneuro.9b00685","article-title":"Neurotrophic effects of vascular endothelial growth factor B and novel mimetic peptides on neurons from the central nervous system","volume":"11","author":"Dmytriyeva","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib68","doi-asserted-by":"crossref","first-page":"14389","DOI":"10.1073\/pnas.95.24.14389","article-title":"Vascular endothelial growth factor C induces angiogenesis in vivo","volume":"95","author":"Cao","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib69","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","article-title":"Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)","volume":"95","author":"Achen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2016.08.008","article-title":"Pathway-related molecules of VEGFC\/D-VEGFR3\/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis","volume":"461","author":"Wang","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phrs.2024.107101_bib71","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0006-291X(02)00677-0","article-title":"Loss of placental growth factor protects mice against vascular permeability in pathological conditions","volume":"295","author":"Luttun","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2024.107101_bib72","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib73","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood-2002-05-1516","article-title":"A critical role of placental growth factor in the induction of inflammation and edema formation","volume":"101","author":"Oura","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2024.107101_bib74","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI26772","article-title":"Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair","volume":"116","author":"Maes","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107101_bib75","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.24289","article-title":"Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation","volume":"60","author":"Yoo","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2024.107101_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","article-title":"HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF","volume":"19","author":"Rolny","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2024.107101_bib77","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.2018","article-title":"Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth","volume":"15","author":"Albuquerque","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib78","first-page":"1","article-title":"Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1","author":"Luo","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2024.107101_bib79","first-page":"69","article-title":"Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis","volume":"23","author":"Palmer","year":"2017","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.phrs.2024.107101_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-015-0487-4","article-title":"Soluble Flt-1 links microvascular disease with heart failure in CKD","volume":"110","author":"Di Marco","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.phrs.2024.107101_bib81","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/SHK.0b013e31815072c1","article-title":"A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis","volume":"29","author":"Shapiro","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.phrs.2024.107101_bib82","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2008.06.002","article-title":"Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment","volume":"44","author":"Jaroszewicz","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.phrs.2024.107101_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18040753","article-title":"Serum concentrations of angiopoietin-2 and soluble fms-like tyrosine kinase 1 (SFlt-1) are associated with coagulopathy among patients with acute pancreatitis","volume":"18","author":"Dumnicka","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib84","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2133.2010.10200.x","article-title":"Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: Role in tumour progression","volume":"164","author":"Ruffini","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2024.107101_bib85","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/BJ20100580","article-title":"Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas","volume":"435","author":"Pellet-Many","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.phrs.2024.107101_bib86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3892\/ijo.2013.1948","article-title":"Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms","volume":"43","author":"Ruffini","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.phrs.2024.107101_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2023.106782","article-title":"Targeting of PDGF-C\/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors","volume":"192","author":"Ruffini","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib88","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","article-title":"High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis","volume":"72","author":"Millauer","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107101_bib89","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00018-013-1280-x","article-title":"Delineating multiple functions of VEGF-A in the adult brain","volume":"70","author":"Licht","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib90","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1073\/pnas.1007640108","article-title":"Reversible modulations of neuronal plasticity by VEGF","volume":"108","author":"Licht","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib91","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1073\/pnas.97.18.10242","article-title":"Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia","volume":"97","author":"Jin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib92","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bies.20092","article-title":"VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection","volume":"26","author":"Storkebaum","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.phrs.2024.107101_bib93","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.freeradbiomed.2013.05.036","article-title":"Signaling through the vascular endothelial growth factor receptor VEGFR-2 protects hippocampal neurons from mitochondrial dysfunction and oxidative stress","volume":"63","author":"Hao","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib94","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ajpath.2013.05.031","article-title":"VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro","volume":"183","author":"Beazley-Long","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2024.107101_bib95","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.neuint.2011.07.005","article-title":"PI3-K\/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis","volume":"59","author":"Cui","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2024.107101_bib96","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2024.107101_bib97","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4161\/cam.22408","article-title":"Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity","volume":"6","author":"Tillo","year":"2012","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.phrs.2024.107101_bib98","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1248\/bpb.b12-00841","article-title":"Vascular endothelial growth factor modulates voltage-gated Na(+) channel properties and depresses action potential firing in cultured rat hippocampal neurons","volume":"36","author":"Sun","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2024.107101_bib99","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0306-4522(02)00948-X","article-title":"Vascular endothelial growth factor inhibits outward delayed-rectifier potassium currents in acutely isolated hippocampal neurons","volume":"118","author":"Xu","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107101_bib100","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cellsig.2007.12.009","article-title":"Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium\/calmodulin protein kinase II and mammalian target of rapamycin","volume":"20","author":"Kim","year":"2008","journal-title":"Cell Signal."},{"key":"10.1016\/j.phrs.2024.107101_bib101","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jnr.21859","article-title":"Vascular endothelial growth factor acutely reduces calcium influx via inhibition of the Ca2+ channels in rat hippocampal neurons","volume":"87","author":"Ma","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib102","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.1073\/pnas.1100341108","article-title":"VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation","volume":"108","author":"Meissirel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib103","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1073\/pnas.1007640108","article-title":"Reversible modulations of neuronal plasticity by VEGF","volume":"108","author":"Licht","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib104","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/mp.2015.195","article-title":"A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior","volume":"21","author":"De Rossi","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107101_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2019.00113","article-title":"Blocking VEGF by bevacizumab compromises electrophysiological and morphological properties of hippocampal neurons","volume":"13","author":"Latzer","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib106","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12017-013-8284-4","article-title":"VEGF ameliorates cognitive impairment in in vivo and in vitro ischemia via improving neuronal viability and function","volume":"16","author":"Yang","year":"2014","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib107","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12017-017-8458-6","article-title":"VEGF-mediated cognitive and synaptic improvement in chronic cerebral hypoperfusion rats involves autophagy process","volume":"19","author":"Wang","year":"2017","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib108","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12017-020-08642-y","article-title":"VEGF modulates the neural dynamics of hippocampal subregions in chronic global cerebral ischemia rats","volume":"23","author":"Wang","year":"2021","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib109","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng1395","article-title":"VEGF links hippocampal activity with neurogenesis, learning and memory","volume":"36","author":"Cao","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2024.107101_bib110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.expneurol.2018.12.005","article-title":"Treadmill exercise ameliorates focal cerebral ischemia\/reperfusion-induced neurological deficit by promoting dendritic modification and synaptic plasticity via upregulating caveolin-1\/VEGF signaling pathways","volume":"313","author":"Xie","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib111","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.neuroscience.2015.10.038","article-title":"Repetitive transcranial magnetic stimulation enhances spatial learning and synaptic plasticity via the VEGF and BDNF-NMDAR pathways in a rat model of vascular dementia","volume":"311","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107101_bib112","doi-asserted-by":"crossref","first-page":"17272","DOI":"10.1073\/pnas.1407227111","article-title":"VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions","volume":"111","author":"Guaiquil","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib113","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1523\/JNEUROSCI.1092-08.2008","article-title":"Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration","volume":"28","author":"Poesen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-4-49","article-title":"Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson\u2019s disease","volume":"4","author":"Falk","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2024.107101_bib115","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/01.WCB.0000134477.38980.38","article-title":"Increased severity of cerebral ischemic injury in vascular endothelial growth factor-B-deficient mice","volume":"24","author":"Sun","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.phrs.2024.107101_bib116","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nn1646","article-title":"VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain","volume":"9","author":"Le Bras","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib117","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneuroim.2019.04.016","article-title":"VEGF- and PDGF-dependent proliferation of oligodendrocyte progenitor cells in the medulla oblongata after LPC-induced focal demyelination","volume":"332","author":"Hiratsuka","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2024.107101_bib118","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.celrep.2015.01.049","article-title":"Vascular endothelial growth factor receptor 3 controls neural stem cell activation in mice and humans","volume":"10","author":"Han","year":"2015","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2024.107101_bib119","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuron.2011.04.022","article-title":"Nuclear calcium-VEGFD signaling controls maintenance of dendrite arborization necessary for memory formation","volume":"71","author":"Mauceri","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107101_bib120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbi.2021.08.007","article-title":"Chronic VEGFR-3 signaling preserves dendritic arborization and sensitization under stress","volume":"98","author":"Chakraborty","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2024.107101_bib121","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1073\/pnas.2001563117","article-title":"Nasally delivered VEGFD mimetics mitigate stroke-induced dendrite loss and brain damage","volume":"117","author":"Mauceri","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib122","first-page":"1","article-title":"EGFL7 loss correlates with increased VEGF-D expression, upregulating hippocampal adult neurogenesis and improving spatial learning and memory","volume":"80","author":"Barth","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib123","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/molehr\/gav069","article-title":"Placental growth factor deficiency is associated with impaired cerebral vascular development in mice","volume":"22","author":"Luna","year":"2022","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.phrs.2024.107101_bib124","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1172\/JCI60842","article-title":"Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease","volume":"122","author":"Argaw","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107101_bib125","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Jain","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib126","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/BF03401866","article-title":"VEGF-D is an X-linked\/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme","volume":"7","author":"Debinski","year":"2001","journal-title":"Mol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib127","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11060-006-9272-4","article-title":"Expression of VEGFR3 in glioma endothelium correlates with tumor grade","volume":"82","author":"Grau","year":"2007","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.phrs.2024.107101_bib128","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1073\/pnas.1423278112","article-title":"VEGFR3 does not sustain retinal angiogenesis without VEGFR2","volume":"112","author":"Zarkada","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib129","doi-asserted-by":"crossref","first-page":"11946","DOI":"10.1073\/pnas.182296499","article-title":"Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107101_bib130","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/glia.24361","article-title":"Vascular endothelial growth factor promotes transdifferentiation of astrocytes into neurons via activation of the MAPK\/Erk-Pax6 signal pathway","volume":"71","author":"Lei","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2024.107101_bib131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-5728(02)00315-6","article-title":"Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells","volume":"132","author":"Forstreuter","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2024.107101_bib132","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.expneurol.2004.12.022","article-title":"Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways","volume":"192","author":"Mani","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib133","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1523\/JNEUROSCI.5527-08.2009","article-title":"VEGFR-1 regulates adult olfactory bulb neurogenesis and migration of neural progenitors in the rostral migratory stream in vivo","volume":"29","author":"Wittko","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2019.00270","article-title":"Early post-stroke activation of vascular endothelial growth factor receptor 2 hinders the receptor 1-dependent neuroprotection afforded by the endogenous ligand","volume":"13","author":"C\u00e1rdenas-Rivera","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02127-x","article-title":"VEGF-A\/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody","volume":"40","author":"Micheli","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107101_bib136","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2013.03.050","article-title":"Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies","volume":"244","author":"Verheyen","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107101_bib137","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/dbio.1995.1208","article-title":"Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system","volume":"170","author":"Takagi","year":"1995","journal-title":"Dev. Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib138","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(00)80534-6","article-title":"Neuropilin is a receptor for the axonal chemorepellent semaphorin III","volume":"90","author":"He","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107101_bib139","doi-asserted-by":"crossref","first-page":"18040","DOI":"10.1074\/jbc.M909259199","article-title":"Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF","volume":"275","author":"Gluzman-Poltorak","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107101_bib140","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1242\/dev.070037","article-title":"The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins","volume":"138","author":"Fantin","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.phrs.2024.107101_bib141","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.02.003","article-title":"NRP1 function and targeting in neurovascular development and eye disease","volume":"52","author":"Raimondi","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.phrs.2024.107101_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2015.00125","article-title":"Neuropilin-1 as therapeutic target for malignant melanoma","volume":"5","author":"Graziani","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2024.107101_bib143","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00262-013-1500-0","article-title":"Neuropilin 1: function and therapeutic potential in cancer","volume":"63","author":"Chaudhary","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.phrs.2024.107101_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2012.00071","article-title":"Semaphorin signaling in vertebrate neural circuit assembly","volume":"5","author":"Yoshida","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1242\/dev.072348","article-title":"Diverse roles for VEGF-A in the nervous system","volume":"139","author":"Mackenzie","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.phrs.2024.107101_bib146","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1242\/dev.103028","article-title":"Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis","volume":"141","author":"Fantin","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.phrs.2024.107101_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.03720","article-title":"Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding","volume":"3","author":"Gelfand","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2024.107101_bib148","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2024.107101_bib149","first-page":"1","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2024.107101_bib150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-015-0531-7","article-title":"The role of neuroinflammation in dementias","volume":"15","author":"Pasqualetti","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.phrs.2024.107101_bib152","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1177\/0271678X20982383","article-title":"Causes and consequences of baseline cerebral blood flow reductions in Alzheimer\u2019s disease","volume":"41","author":"Bracko","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.phrs.2024.107101_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/life13010221","article-title":"Involvement of an aberrant vascular system in neurodevelopmental, neuropsychiatric, and neuro-degenerative diseases","volume":"13","author":"Ishihara","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.phrs.2024.107101_bib154","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.expneurol.2005.12.016","article-title":"Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus","volume":"198","author":"Ryu","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib155","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","article-title":"\u03b2-amyloid stimulation of microglia anti monocytes results in TNF\u03b1-dependent expression of inducible nitric oxide synthase and neuronal apoptosis","volume":"21","author":"Combs","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib156","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10456-006-9055-8","article-title":"Vascular endothelial growth factor receptor-1 (VEGFR-1\/Flt-1): a dual regulator for angiogenesis","volume":"9","author":"Shibuya","year":"2006","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phrs.2024.107101_bib157","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/ATVBAHA.107.158022","article-title":"The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes","volume":"28","author":"Tchaikovski","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib158","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1523\/JNEUROSCI.2888-08.2009","article-title":"Microglial VEGF receptor response is an integral chemotactic component in Alzheimer\u2019s disease pathology","volume":"29","author":"Ryu","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib159","first-page":"149","article-title":"Paeoniflorin attenuates A\u03b21-42-induced inflammation and chemotaxis of microglia in vitro and inhibits NF-\u03baB- and VEGF\/Flt-1 signaling pathways","volume":"2015","author":"Liu","year":"1618","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2024.107101_bib160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-2010-100471","article-title":"Amyloid-\u03b225-35, an amyloid-\u03b21-42 surrogate, and proinflammatory cytokines stimulate VEGF-a secretion by cultured, early passage, normoxic adult human cerebral astrocytes","volume":"21","author":"Chiarini","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib161","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s12017-014-8315-9","article-title":"The A\u03b2 peptides-activated calcium-sensing receptor stimulates the production and secretion of vascular endothelial growth factor-a by normoxic adult human cortical astrocytes","volume":"16","author":"Dal Pr\u00e0","year":"2014","journal-title":"NeuroMol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib162","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/1673-5374.152373","article-title":"Antagonizing amyloid-\u03b2\/calcium-sensing receptor signaling in human astrocytes and neurons: a key to halt Alzheimer\u2019s disease progression?","volume":"10","author":"Dal Pra","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib163","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jnc.14068","article-title":"Astrocytes contribute to A\u03b2-induced blood\u2013brain barrier damage through activation of endothelial MMP9","volume":"142","author":"Spampinato","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2024.107101_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23031878","article-title":"Murine beta-amyloid ( 1 \u2013 42) oligomers disrupt endothelial barrier integrity and VEGFR signaling via activating astrocytes to release deleterious soluble factors","volume":"23","author":"Yue","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib165","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","article-title":"Beta-amyloid, blood vessels and brain function NIH public access","volume":"40","author":"Smith","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2024.107101_bib166","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: a matter of blood \u2013 brain barrier dysfunction\u00a0?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep02053","article-title":"VEGF significantly restores impaired memory behavior in Alzheimer\u2019s mice by improvement of vascular survival","volume":"3","author":"Religa","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107101_bib168","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/B:AGEN.0000037335.17717.bf","article-title":"Inhibition of angiogenesis by A\u03b2 peptides","volume":"7","author":"Paris","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phrs.2024.107101_bib169","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.neurobiolaging.2012.10.029","article-title":"Expression level of vascular endothelial growth factor in hippocampus is associated with cognitive impairment in patients with Alzheimer\u2019s disease","volume":"34","author":"Tang","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2024.107101_bib170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0197-4580(01)00285-8","article-title":"Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia","volume":"23","author":"Tarkowski","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2024.107101_bib171","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10522-011-9335-6","article-title":"Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration","volume":"12","author":"Corsi","year":"2011","journal-title":"Biogerontology"},{"key":"10.1016\/j.phrs.2024.107101_bib172","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijdevneu.2009.06.011","article-title":"Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and \u03b2-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain","volume":"27","author":"B\u00fcrger","year":"2009","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib173","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neures.2018.04.003","article-title":"Vascular endothelial growth factor improves the cognitive decline of Alzheimer\u2019s disease via concurrently inducing the expression of ADAM10 and reducing the expression of \u03b2-site APP cleaving enzyme 1 in Tg2576 mice","volume":"142","author":"Guo","year":"2019","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib174","first-page":"2389","article-title":"Therapeutic approaches to Alzheimer\u2019s disease through stimulating of non-amyloidogenic processing of amyloid precursor protein","volume":"20","author":"Wang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","article-title":"Functions of A\u03b2, sAPP\u03b1 and sAPP\u03b2: similarities and differences","volume":"120","author":"Chasseigneaux","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2024.107101_bib176","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1172\/JCI21746","article-title":"Amyloid at the cutting edge: activation of \u03b1-secretase prevents amyloidogenesis in an Alzheimer disease mouse model","volume":"113","author":"Lichtenthaler","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107101_bib177","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/awab387","article-title":"VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer\u2019s mice","volume":"145","author":"Ali","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2024.107101_bib178","doi-asserted-by":"crossref","first-page":"47622","DOI":"10.1002\/alz.047622","article-title":"Inhibition of peripheral VEGF signaling rapidly reduces leucocyte obstructions in brain capillaries and improves cortical blood flow in an Alzheimer\u2019s disease mouse model","volume":"16","author":"Ali","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.phrs.2024.107101_bib179","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3233\/JAD-121636","article-title":"Neurovascular unit and the effects of dosage in VEGF toxicity: role for oxidative stress and thrombin","volume":"34","author":"Sanchez","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1567202611666140520122316","article-title":"Reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in Alzheimer\u2019s disease","volume":"11","author":"Provias","year":"2014","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib181","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2013.06.031","article-title":"Decreased serum levels of the angiogenic factors VEGF and TGF-\u03b21 in Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"550","author":"Huang","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2024.107101_bib182","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2013.04.028","article-title":"VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP\/Ps1 mouse model of Alzheimer\u2019s disease","volume":"170","author":"Herr\u00e1n","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2024.107101_bib183","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1016\/j.biomaterials.2010.03.042","article-title":"The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer\u2019s disease","volume":"31","author":"Spuch","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107101_bib184","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-111646","article-title":"Encapsulated VEGF-secreting cells enhance proliferation of neuronal progenitors in the hippocampus of APP\/PS1 mice","volume":"29","author":"Antequera","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2014.00030","article-title":"Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of alzheimer\u2019s disease","volume":"6","author":"Garcia","year":"2014","journal-title":"Front. Aging Neurosci.."},{"key":"10.1016\/j.phrs.2024.107101_bib186","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bbrc.2011.07.003","article-title":"VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer\u2019s disease","volume":"411","author":"Wang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2024.107101_bib187","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/00207454.2020.1733564","article-title":"Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer\u2019s disease","volume":"131","author":"Liu","year":"2021","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib188","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s11011-021-00751-2","article-title":"Exercise training ameliorates cognitive dysfunction in amyloid beta \u2011 injected rat model: possible mechanisms of Angiostatin\/VEGF signaling","volume":"36","author":"Zarezadehmehrizi","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib189","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2003.03041.x","article-title":"VEGF is necessary for exercise-induced adult hippocampal neurogenesis","volume":"18","author":"Fabel","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib190","first-page":"1","article-title":"VEGF-A in serum protects against memory impairment in APP\/PS1 transgenic mice by blocking neutrophil infiltration","volume":"July 2022","author":"Qi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107101_bib191","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ana.25159","article-title":"Neutrophil hyperactivation correlates with Alzheimer\u2019s disease progression","volume":"83","author":"Dong","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2020.523798","article-title":"PET imaging of neutrophils infiltration in Alzheimer\u2019s disease transgenic mice","volume":"11","author":"Kong","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2021.109121","article-title":"VEGF counteracts amyloid-\u03b2-induced synaptic dysfunction","volume":"35","author":"Martin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107101_bib194","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1471-4159.2009.06426.x","article-title":"Alzheimer\u2019s \u03b2-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2","volume":"112","author":"Patel","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2024.107101_bib195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0197-4580(03)00111-8","article-title":"Co-accumulation of vascular endothelial growth factor with \u03b2-amyloid in the brain of patients with Alzheimer\u2019s disease","volume":"25","author":"Yang","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2024.107101_bib196","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/13506120701814723","article-title":"Potent anti-angiogenic motifs within the Alzheimer \u03b2-amyloid peptide","volume":"15","author":"Patel","year":"2008","journal-title":"Amyloid"},{"key":"10.1016\/j.phrs.2024.107101_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acel.13907","article-title":"A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity","volume":"22","author":"Bouvet","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.phrs.2024.107101_bib198","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1096\/fj.201802003R","article-title":"VEGF receptor-1 modulates amyloid \u03b2 1\u201342 oligomer-induced senescence in brain endothelial cells","volume":"33","author":"Angom","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2024.107101_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-18042-1","article-title":"VEGFR2 alteration in Alzheimer\u2019s disease","volume":"7","author":"Cho","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107101_bib200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000049150","article-title":"Small vessel disease and alzheimer\u2019s dementia: pathological considerations","volume":"13","author":"Kalaria","year":"2002","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib201","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.1997.tb48462.x","article-title":"Hemodynamic consequences of deformed microvessels in the brain in Alzheimer\u2019s disease","volume":"826","author":"De la Torre","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms24054510","article-title":"Alzheimer\u2019s amyloid \u03b2 peptide induces angiogenesis in an Alzheimer\u2019s disease model mouse through placental growth factor and angiopoietin 2 expressions","volume":"24","author":"Sheikh","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib203","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s11064-014-1313-3","article-title":"Diazoxide pretreatment prevents A\u03b21-42 induced oxidative stress in cholinergic neurons via alleviating NOX2 expression","volume":"39","author":"Fu","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib204","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1471-4159.2002.00958.x","article-title":"Generation of reactive oxygen species and activation of NF-\u03bab by non-A\u03b2 component of Alzheimer\u2019s disease amyloid","volume":"82","author":"Tanaka","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2024.107101_bib205","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4103\/1673-5374.230299","article-title":"Induced dural lymphangiogenesis facilities soluble amyloid-beta clearance from brain in a transgenic mouse model of Alzheimer\u2019s disease","volume":"13","author":"Wen","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","article-title":"Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease","volume":"560","author":"Da Mesquita","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107101_bib207","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41586-021-03489-0","article-title":"Meningeal lymphatics affect microglia responses and anti-A\u03b2 immunotherapy","volume":"593","author":"Da Mesquita","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107101_bib208","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijdevneu.2015.03.003","article-title":"Expression of vascular endothelial growth factor (VEGF) mRNA, VEGF receptor 2 (Flk-1) mRNA, and of VEGF co-receptor neuropilin (Nrp)-1 mRNA in brain tissue of aging Tg2576 mice by in situ hybridization","volume":"43","author":"Muche","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2021.741175","article-title":"Identifying new COVID-19 receptor neuropilin-1 in severe Alzheimer\u2019s disease patients group brain using genome-wide association study approach","volume":"12","author":"Lim","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.phrs.2024.107101_bib210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2021.102075","article-title":"Plexin-A4 mediates amyloid- \u03b2 \u2013 induced tau pathology in Alzheimer\u2019s disease animal model","volume":"203","author":"Chung","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107101_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2023.1308345","article-title":"New insight on microglia activation in neurodegenerative diseases and therapeutics","volume":"17","author":"Xu","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib212","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson\u2019s disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2024.107101_bib213","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/10738584211011979","article-title":"Non-motor symptoms of Parkinson\u2019s disease: the neurobiology of early psychiatric and cognitive dysfunction","volume":"29","author":"Hussein","year":"2023","journal-title":"Neuroscientist"},{"key":"10.1016\/j.phrs.2024.107101_bib214","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2014.00211","article-title":"Astrocytic modulation of blood brain barrier: perspectives on Parkinson\u2019s disease","volume":"8","author":"Cabezas","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib216","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","article-title":"Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration","volume":"19","author":"Patani","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-021-00265-y","article-title":"Astrocyte dysfunction in Parkinson\u2019s disease: from the perspectives of transmitted \u03b1-synuclein and genetic modulation","volume":"10","author":"Wang","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.phrs.2024.107101_bib218","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(71)90439-2","article-title":"Neuronal vascular relationships in the zona compacta of normal and parkinsonian substantia nigra","volume":"25","author":"Issidorides","year":"1971","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2024.107101_bib219","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","article-title":"Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease","volume":"353","author":"Faucheux","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2024.107101_bib220","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib221","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/brain\/awr165","article-title":"Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: Implications for the development of dyskinesia","volume":"134","author":"Ohlin","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2024.107101_bib222","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mds.25066","article-title":"Impairment of brain vessels may contribute to mortality in patients with Parkinson\u2019s disease","volume":"27","author":"Rektor","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2024.107101_bib223","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1750-3639.2012.00628.x","article-title":"Vascular degeneration in parkinsons disease","volume":"23","author":"Guan","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.phrs.2024.107101_bib224","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s10072-016-2691-x","article-title":"Association of VEGF gene polymorphisms with sporadic Parkinson\u2019s disease in Chinese Han population","volume":"37","author":"Wu","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2011.02.027","article-title":"VEGF polymorphisms and serum VEGF levels in Parkinson\u2019s disease","volume":"494","author":"Mihci","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2024.107101_bib226","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1212\/WNL.0000000000002151","article-title":"Increased CSF biomarkers of angiogenesis in Parkinson disease","volume":"85","author":"Janelidze","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2024.107101_bib227","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0404.2006.00775.x","article-title":"Low serum VEGF levels are associated with Alzheimer\u2019s disease","volume":"116","author":"Mateo","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.phrs.2024.107101_bib228","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.wnr.0000215769.71657.65","article-title":"Expression levels of vascular endothelial growth factor and its receptors in Parkinson\u2019s disease","volume":"17","author":"Wada","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2024.107101_bib229","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-004-0256-2","article-title":"Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian","volume":"112","author":"Barcia","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.phrs.2024.107101_bib230","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/glia.24109","article-title":"Astrocytic VEGFA: an essential mediator in blood\u2013brain-barrier disruption in Parkinson\u2019s disease","volume":"70","author":"Lan","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2024.107101_bib231","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23052646","article-title":"Key role of astrocytes in postnatal brain and retinal angiogenesis","volume":"23","author":"Puebla","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib232","article-title":"VEGFA mediates blood\u2013brain barrier disruption in Parkinson disease","volume":"18","author":"Wood","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23094508","article-title":"Pathophysiological features of nigral dopaminergic neurons in animal models of Parkinson's disease","volume":"23","author":"Guatteo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib234","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2004.01.022","article-title":"New roles for VEGF in nervous tissue - beyond blood vessels","volume":"187","author":"Rosenstein","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI20682","article-title":"VEGF: a critical player in neurodegeneration","volume":"113","author":"Storkebaum","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2024.107101_bib236","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0014-4886(03)00100-6","article-title":"Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells","volume":"182","author":"Pitzer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib237","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0306-4522(98)00540-5","article-title":"Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures","volume":"90","author":"Silverman","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107101_bib238","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1523\/JNEUROSCI.2521-09.2009","article-title":"Semaphorin 3F is a bifunctional guidance cue for dopaminergic axons and controls their fasciculation, channeling, rostral growth, and intracortical targeting","volume":"29","author":"Kolk","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib239","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1523\/JNEUROSCI.4794-08.2009","article-title":"FGF8 signaling regulates growth of midbrain dopaminergic axons by inducing semaphorin 3F","volume":"29","author":"Yamauchi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib240","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jnr.22268","article-title":"Axon responses of embryonic stem cell-derived dopaminergic neurons to semaphorins 3A and 3C","volume":"88","author":"Tamariz","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib241","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mcn.2010.03.003","article-title":"Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype","volume":"44","author":"Torre","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib242","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ejn.12190","article-title":"Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons","volume":"37","author":"Torigoe","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib243","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1460-9568.2004.03254.x","article-title":"Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson\u2019s disease","volume":"19","author":"Yasuhara","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib244","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.05.027","article-title":"Neurorescue effects of VEGF on a rat model of Parkinson\u2019s disease","volume":"1053","author":"Yasuhara","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2024.107101_bib245","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/gt.2010.152","article-title":"VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinsons disease","volume":"18","author":"Xiong","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.phrs.2024.107101_bib246","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ejpb.2013.03.034","article-title":"In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson\u2019s disease","volume":"85","author":"Herr\u00e1n","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.phrs.2024.107101_bib247","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neulet.2007.05.033","article-title":"Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors","volume":"421","author":"Tian","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2024.107101_bib248","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.actbio.2016.12.048","article-title":"Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson\u2019s Disease (PD","volume":"54","author":"Sheikh","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2024.107101_bib249","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/cbdd.13681","article-title":"Vascular endothelial growth factor-loaded poly-lactic-co-glycolic acid nanoparticles with controlled release protect the dopaminergic neurons in Parkinson\u2019s rats","volume":"95","author":"Meng","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.phrs.2024.107101_bib250","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000511121","article-title":"The effects of deep brain stimulation of the subthalamic nucleus on vascular endothelial growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in a rat model of Parkinson\u2019s disease","volume":"99","author":"Faust","year":"2021","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.phrs.2024.107101_bib251","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2014.12.006","article-title":"Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease","volume":"74","author":"Pienaar","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib252","first-page":"2833","article-title":"Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson's disease","volume":"18","author":"Dong","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib253","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.WNL.0000151960.28687.93","article-title":"Physical activity and the risk of Parkinson disease","volume":"64","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2024.107101_bib254","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jamaneurol.2017.3517","article-title":"Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo parkinson disease: a phase 2 randomized clinical trial","volume":"75","author":"Schenkman","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib255","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(19)30285-6","article-title":"Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial","volume":"18","author":"van der Kolk","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib256","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/mds.27865","article-title":"Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease","volume":"34","author":"Sacheli","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2024.107101_bib257","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.26291","article-title":"Aerobic exercise alters brain function and structure in parkinson's disease: a randomized controlled trial","volume":"91","author":"Johansson","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib258","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2017.05.016","article-title":"Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2\/MyD88\/NF-\u03baB signaling pathway","volume":"356","author":"Koo","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107101_bib259","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12965\/jer.1734906.453","article-title":"Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats","volume":"13","author":"Shin","year":"2017","journal-title":"J. Exerc. Rehabil."},{"key":"10.1016\/j.phrs.2024.107101_bib260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.adh1403","article-title":"Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity","volume":"9","author":"Marino","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2024.107101_bib261","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2021.111384","article-title":"Effects of task-oriented training combined with aerobic training on serum BDNF, GDNF, IGF-1, VEGF, TNF-\u03b1, and IL-1\u03b2 levels in people with Parkinson's disease: a randomized controlled study","volume":"150","author":"Soke","year":"2021","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.phrs.2024.107101_bib262","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jcbfm.2008.127","article-title":"Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra, Implications for Parkinson's disease","volume":"29","author":"Villar-Cheda","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.phrs.2024.107101_bib263","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/gerona\/gly072","article-title":"Physical exercise improves aging-related changes in angiotensin, IGF-1, SIRT1, SIRT3, and VEGF in the Substantia Nigra","volume":"73","author":"Mu\u00f1oz","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib264","first-page":"369","article-title":"Endurance exercise training promotes angiogenesis in the brain of chronic\/progressive mouse model of Parkinson's Disease","volume":"26","author":"Al-Jarrah","year":"2010","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.phrs.2024.107101_bib265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.12.055","article-title":"The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson\u2019s disease model","volume":"1038","author":"Yasuhara","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2024.107101_bib266","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04567.x","article-title":"Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons","volume":"101","author":"Rite","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2024.107101_bib267","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mds.23959","article-title":"Pain in Parkinson\u2019s disease","volume":"27","author":"Ha","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.phrs.2024.107101_bib268","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/09636897221149130","article-title":"VEGF-expressing mesenchymal stem cell therapy for safe and effective treatment of pain in Parkinson\u2019s disease","volume":"32","author":"Li","year":"2023","journal-title":"Cell Transpl."},{"key":"10.1016\/j.phrs.2024.107101_bib269","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2011.03.088","article-title":"Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson\u2019s disease","volume":"496","author":"Falk","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2024.107101_bib270","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.neuroscience.2011.06.084","article-title":"Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo","volume":"192","author":"Piltonen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107101_bib271","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12035-017-0733-x","article-title":"Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson\u2019s disease","volume":"55","author":"Requejo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107101_bib272","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2017.240","article-title":"Cystatin C as a potential therapeutic mediator against Parkinson\u2019s disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units","volume":"8","author":"Zou","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib273","first-page":"1","article-title":"Insights into the mechanisms involved in protective effects of VEGF-B in dopaminergic neurons","volume":"2017","author":"Caballero","year":"2017","journal-title":"Park. Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib274","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107101_bib275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13091337","article-title":"Peptide inhibitors of vascular endothelial growth factor a: current situation and perspectives","volume":"13","author":"Guryanov","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2024.107101_bib276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-022-01310-7","article-title":"Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2024.107101_bib277","first-page":"1","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2023 update","volume":"187","author":"Roskoski","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib278","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1681\/ASN.2018080853","article-title":"Therapeutic inhibition of VEGF signaling and associated nephrotoxicities","volume":"30","author":"Estrada","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2024.107101_bib279","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2024.107101_bib280","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/annonc\/mdw412","article-title":"Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy","volume":"27","author":"Moore","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phrs.2024.107101_bib281","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1634\/theoncologist.2016-0265","article-title":"Randomized phase II study of ramucirumab or icrucumab in combination with capecitabine in patients with previously treated locally advanced or metastatic breast cancer","volume":"22","author":"Vahdat","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.phrs.2024.107101_bib282","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1158\/1078-0432.CCR-06-0831","article-title":"Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer","volume":"12","author":"Wu","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107101_bib283","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.leukres.2009.03.006","article-title":"Growth inhibition of AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for vascular endothelial growth factor","volume":"33","author":"Imai","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.phrs.2024.107101_bib284","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/14712598.2012.679655","article-title":"Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy","volume":"12","author":"Nielsen","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.phrs.2024.107101_bib285","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V97.3.785","article-title":"Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans","volume":"97","author":"Sawano","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2024.107101_bib286","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.phrs.2024.107101_bib287","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13110394","article-title":"Treatment of alzheimer\u2019s disease and blood\u2013brain barrier drug delivery","volume":"13","author":"Pardridge","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phrs.2024.107101_bib288","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107101_bib289","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.phrs.2024.107101_bib290","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/13543784.2019.1627325","article-title":"Alzheimer\u2019s disease: future drug development and the blood-brain barrier","volume":"28","author":"Pardridge","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.phrs.2024.107101_bib291","first-page":"1","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801 - the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.phrs.2024.107101_bib292","first-page":"1","article-title":"Safety and tolerability of BAN2401 - a clinical study in Alzheimer\u2019s disease with a protofibril selective A\u03b2 antibody","volume":"8","author":"Logovinsky","year":"2016","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.phrs.2024.107101_bib293","first-page":"1","article-title":"ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer\u2019s disease","volume":"9","author":"Honig","year":"2023","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.phrs.2024.107101_bib294","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.adi2242","article-title":"Report on trial death stokes Alzheimer's drug fears","volume":"380","author":"Piller","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107101_bib295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2022.108119","article-title":"Blood-brain barrier leakage in Alzheimer\u2019s disease: from discovery to clinical relevance","volume":"234","author":"Nehra","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2024.107101_bib296","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","article-title":"A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk","volume":"603","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107101_bib297","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/08977194.2022.2074843","article-title":"An appraisal of vascular endothelial growth factor (VEGF): the dynamic molecule of wound healing and its current clinical applications","volume":"40","author":"Goswami","year":"2022","journal-title":"Growth Factors"},{"key":"10.1016\/j.phrs.2024.107101_bib298","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107101_bib299","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.addr.2011.12.005","article-title":"Drug delivery to the brain in Alzheimer\u2019s disease: consideration of the blood-brain barrier","volume":"64","author":"Banks","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107101_bib300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18091965","article-title":"Blood-brain barrier dysfunction and the pathogenesis of alzheimer\u2019s disease","volume":"18","author":"Yamazaki","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib301","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood\u2013brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2024.107101_bib302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0577-2","article-title":"The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells","volume":"36","author":"Atzori","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107101_bib303","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/jpet.117.244434","article-title":"The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits glioma growth and angiogenesis in vivo","volume":"364","author":"Atzori","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2024.107101_bib304","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/jcmm.14755","article-title":"Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib","volume":"24","author":"Atzori","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107101_bib305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers14225578","article-title":"The anti-vascular endothelial growth factor receptor 1 (VEGFR-1) D16F7 monoclonal antibody inhibits melanoma adhesion to soluble VEGFR-1 and tissue invasion in response to placenta growth factor","volume":"14","author":"Atzori","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107101_bib306","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2015.09.036","article-title":"Lack of widespread BBB disruption in Alzheimer\u2019s disease models: focus on therapeutic antibodies","volume":"88","author":"Bien-Ly","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107101_bib307","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-013-0187-4","article-title":"Developing therapeutic antibodies for neurodegenerative disease","volume":"10","author":"Yu","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2024.107101_bib308","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/15672050113106660176","article-title":"Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer\u2019s disease","volume":"11","author":"Zhao","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.phrs.2024.107101_bib309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/980250","article-title":"ScFv antibody: principles and clinical application","volume":"2012","author":"Ahmad","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.phrs.2024.107101_bib310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-61779-191-8_26","article-title":"In vitro and in vivo methods for assessing FcRn-mediated reverse transcytosis across the blood\u2013brain barrier","volume":"763","author":"Caram-Salas","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2024.107101_bib311","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2174\/1570159X17666191113103850","article-title":"Current understanding of central nervous system drainage systems: implications in the context of neurodegenerative diseases","volume":"18","author":"Nikolenko","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2024.107101_bib312","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.bjps.2020.05.009","article-title":"Phase 1 Lymfactin\u24c7 study: short-term safety of combined adenoviral VEGF-C and lymph node transfer treatment for upper extremity lymphedema","volume":"73","author":"Hartiala","year":"2020","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.phrs.2024.107101_bib313","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2023.1243869","article-title":"Exercise therapy to prevent and treat Alzheimer's disease","volume":"15","author":"Pahlavani","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib314","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/230791","article-title":"Exercise training could improve age-related changes in cerebral blood flow and capillary vascularity through the upregulation of VEGF and eNOS","volume":"2014","author":"Viboolvorakul","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phrs.2024.107101_bib315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0361073X.2022.2048586","article-title":"Aerobic training and circulating neurotrophins in alzheimer's disease patients: a controlled trial","volume":"49","author":"Stein","year":"2023","journal-title":"Exp. Aging Res."},{"key":"10.1016\/j.phrs.2024.107101_bib316","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40265-022-01747-7","article-title":"Newly approved and investigational drugs for motor symptom control in Parkinson's disease","volume":"82","author":"Di Luca","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2024.107101_bib317","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clineuro.2017.06.011","article-title":"Deep brain stimulation of subthalamic nucleus helps in improving late phase motor planning in Parkinson's disease","volume":"160","author":"Ashlesh","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.phrs.2024.107101_bib318","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s43440-020-00120-3","article-title":"Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies","volume":"72","author":"Chmielarz","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2024.107101_bib319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2021.682597","article-title":"Neurotrophic factors in Parkinson's disease: clinical trials, open challenges and nanoparticle-mediated delivery to the brain","volume":"15","author":"Bondarenko","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2024.107101_bib320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms222111702","article-title":"Mechanistic insight from preclinical models of Parkinson's disease could help redirect clinical trial efforts in GDNF therapy","volume":"22","author":"Delgado-Minjares","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107101_bib321","doi-asserted-by":"crossref","unstructured":"L. Simoes Braga Boisserand, J. Bouchart, L.H. Geraldo, S. Lee, B.G. Sanganahalli, M. Parent, S. Zhang, Y. Xue, M. Skarica, J. Guegan, M. Li, X. Liu, M. Poulet, M. Askanase, A. Osherov, M. Spajer, M.E. Kamouh, A. Eichmann,\u00a0K. Alitalo, J. Zhou, N. Sestan, L.H. Sansing, H. Benveniste, F. Hyder, J.L. Thomas, VEGF-C promotes brain-derived fluid drainage, confers neuroprotection, and improves stroke outcomes, bioRxiv [Preprint], 2023. \u3008https:\/\/doi.org\/10.1101\/2023.05.30.542708\u3009.","DOI":"10.1101\/2023.05.30.542708"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:51:13Z","timestamp":1760914273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":321,"alternative-id":["S1043661824000458"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107101","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The VEGFs\/VEGFRs system in Alzheimer\u2019s and Parkinson\u2019s diseases: Pathophysiological roles and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107101"}}